Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
- 9 July 2007
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (12) , 1869-1876
- https://doi.org/10.1016/j.ejca.2007.05.013
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasionJournal of Clinical Pathology, 2007
- EMMPRIN‐induced MMP‐2 activation cascade in human cervical squamous cell carcinomaInternational Journal of Cancer, 2006
- Prognostic Value of Intratumoral Neutrophils in Advanced Gastric Carcinoma in a High-Risk Area in Northern ItalyLaboratory Investigation, 2002
- Activity and cellular origin of gelatinases in patients with colon and rectal carcinomaCancer, 2001
- Progelatinase B Forms from Human Neutrophils. Complex Formation of Monomer/Lipocalin with TIMP-1Biological Chemistry Hoppe-Seyler, 1996
- Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cellsFEBS Letters, 1995
- The lipocalin protein family: A role in cell regulationFEBS Letters, 1994
- Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.Gut, 1993
- A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinaseFEBS Letters, 1992
- Enzyme Linked Immunosorbent Assays (ELISA) for the Quantitative Determination of Human Leukocyte Collagenase and Gelatinasecclm, 1989